Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda (NCT06835738) | Clinical Trial Compass
RecruitingNot Applicable
Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda
Uganda4,077 participantsStarted 2025-06-18
Plain-language summary
The objective of this research is to understand how antenatal multiple micronutrient supplements (MMS) can be effectively implemented and scaled within the Uganda national health system context to support improved maternal nutrition and birth outcomes. Formative research has been conducted to design the implementation strategies that will be tested in this second phase of the study. The objectives are to:
* Describe the implementation of the MMS intervention (which consists of MMS product, a social behavior change communication (SBCC) strategy, capacity building, MMS supply chain support, monitoring, and evaluation) and explore acceptability, feasibility, fidelity, coverage, and potential for sustainability.
* Determine the effect of dispensing MMS in different bottle counts on MMS adherence and ANC attendance among pregnant women.
* Determine the cost and budget impact of MMS intervention implementation integrated in the Ugandan ANC service delivery system
Who can participate
Age range
0 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
* ≤24 weeks of amenorrhea/gestation as verified by health professionals
* Attending first ANC visit at government or PNFP health facilities.
* Accepted to take MMS at first ANC visit
Exclusion Criteria for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
* Pregnant women with pre-existing hematological conditions such as sickle cell anemia, thalassemia, hemochromatosis.
* Pregnant women planning to relocate outside the study district during the study period.
Inclusion Criteria for Pregnant women / Women that have recently delivered (single contact) (sample 2)
* Currently pregnant woman or a woman who is not more than 8 weeks postpartum.
* Received MMS at an ANC visit at least 3 months ago or more.
* Attended at least any 2 monthly ANC visits.
* Attending/attended ANC at government or private-not-for-profit health facility.
Exclusion Criteria for Pregnant women / Women that have recently delivered (single contact) (sample 2)
* Enrolled in study population 1.
* Women who are more than 8 weeks postpartum.
Inclusion Criteria for ANC providers having ANC health education/counseling with pregnant woman(en) observed (sample 3)
• Healthcare providers that are currently providing ANC health education (group) or ANC individual counseling at government or PNFP health facilities.
Exclusion Criteria for ANC providers having ANC health education/counseling with preg…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
MMS Adherence (amount) as assessed by number of MMS tablets consumed